Johnson & Johnson (JNJ) Current Taxes (2009 - 2026)
Johnson & Johnson (JNJ) posted Current Taxes of $1.1 billion for Q2 2026, down 3.31% sequentially from $1.1 billion in Q1 2026, and down 36.88% YoY from $1.7 billion in Q2 2025.
Johnson & Johnson (JNJ) Current Taxes (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Current Taxes for 18 years, with the latest figure at $1.1 billion in Q2 2026.
- Quarterly Current Taxes fell 36.88% year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (down 36.88% YoY) and the FY2025 annual result came in at $1.4 billion, down 63.2% from the prior year.
- Current Taxes declined to $1.1 billion in Q2 2026 per JNJ's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Current Taxes peaked at $4.8 billion in Q3 2024 and troughed at $1.1 billion in Q2 2026.
- A 5-year average of $2.6 billion and a median of $2.2 billion in 2023 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2023 and 2026: Current Taxes jumped 149.77% in 2023, then sank 74.22% in 2026.
- Over 5 years, Current Taxes stood at $2.0 billion in 2022, then surged by 50.7% to $3.0 billion in 2023, then increased by 26.03% to $3.8 billion in 2024, then sank by 63.2% to $1.4 billion in 2025, then decreased by 24.28% to $1.1 billion in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.1 billion, $1.1 billion, and $1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.19 Bn | 631.43 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 470.70 Bn | 464.13 Bn | 12.70 Bn | - |
| 3 | Merck | 379.55 Bn | 372.41 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 302.93 Bn | 295.24 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 236.90 Bn | 222.91 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.87 Bn | 179.69 Bn | 6.22 Bn | - |
| 8 | Pfizer | 161.71 Bn | 150.01 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.60 Bn | 101.43 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 55.13 Bn | 47.75 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 1.05 Bn |
| Mar 29, 2026 | 1.09 Bn |
| Dec 28, 2025 | 1.39 Bn |
| Sep 28, 2025 | 1.93 Bn |
| Jun 29, 2025 | 1.67 Bn |
| Mar 30, 2025 | 4.22 Bn |
| Dec 29, 2024 | 3.77 Bn |
| Sep 29, 2024 | 4.83 Bn |
| Jun 30, 2024 | 4.31 Bn |
| Mar 31, 2024 | 3.32 Bn |
| Dec 31, 2023 | 2.99 Bn |
| Oct 1, 2023 | 2.90 Bn |
| Jul 2, 2023 | 2.69 Bn |
| Apr 2, 2023 | 4.27 Bn |
| Jan 1, 2023 | 2.22 Bn |
| Oct 2, 2022 | 1.99 Bn |
| Jul 3, 2022 | 1.98 Bn |
| Apr 3, 2022 | 1.71 Bn |
| Jan 2, 2022 | 1.11 Bn |
| Oct 3, 2021 | 2.16 Bn |